|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| A61K 31/496 | (2006.01) | ||
| A61K 31/5377 | (2006.01) | ||
| A61K 31/4709 | (2006.01) | ||
| A61K 31/454 | (2006.01) | ||
| A61K 31/4439 | (2006.01) |
| (11) | Number of the document | 3986897 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20734871.5 |
| Date of filing the European patent application | 2020-06-19 | |
| (97) | Date of publication of the European application | 2022-04-27 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-30 |
| (46) | Date of publication of the claims translation | 2023-11-10 |
| (86) | Number | PCT/EP2020/067076 |
| Date | 2020-06-19 |
| (87) | Number | WO 2020/254562 |
| Date | 2020-12-24 |
| (30) | Number | Date | Country code |
| 19181754 | 2019-06-21 | EP |
| (72) |
DOLENTE, Cosimo , CH
GOERGLER, Annick , CH
HEWINGS, David , CH
JAESCHKE, Georg , CH
KUHN, Bernd , CH
NAGEL, Yvonne, Alice , CH
OBST SANDER, Ulrike , CH
RICCI, Antonio , CH
RUEHER, Daniel , CH
STEINER, Sandra , CH
|
| (73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | EGFR inhibitorius, skirtas vėžiui gydyti |
| EGFR INHIBITOR FOR THE TREATMENT OF CANCER |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 6 | 139.00 EUR |
| 2026-06-19 |